Randomized Studies are Needed to Assess the True Role of Self-Monitoring of Blood Glucose in Noninsulin-Treated Type 2 Diabetes

Parkin, Christopher G.; Price, David A.

doi:10.1177/193229680700100419

Cited by 7 publications

(3 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This retrospective review of CGM data (i.e., professional CGM) is in contrast to “real-time” personal CGM, which allows for patient direct access to the glucose data. However, there have been recent studies that have called into question the efficacy of recommending SMBG in all patients with T2D, especially those on oral medications without significant risk for hypoglycemia (15–20).…”

Section: Discussionmentioning

confidence: 99%

A Pilot Study to Assess Clinical Utility and User Experience of Professional Continuous Glucose Monitoring Among People With Type 2 Diabetes

et al. 2019

View full text Add to dashboard Cite

IN BRIEF Glucose variability is a potential independent risk factor of poor clinical outcome among people with diabetes, with adequate measurement technically difficult and cumbersome. For this study, a novel 14-day continuous sensor was used to assess glucose variability among people with type 2 diabetes (T2D). The aim was to characterize glucose profiles for up to 2 weeks in T2D and to survey device utilization in a standard clinical setting and its potential to collect clinically meaningful data.

show abstract

Section: Discussionmentioning

confidence: 99%

A Pilot Study to Assess Clinical Utility and User Experience of Professional Continuous Glucose Monitoring Among People With Type 2 Diabetes

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Prior to 2001, data supporting the use of SMBG in non-insulin-treated type 2 diabetes were limited, in spite of increasing SMBG use, leading to repeated calls for more studies in this patient group. 35,36 However, until recently, the majority of randomized controlled trials (nine out of 14 performed up to the year 2010) failed to show any significant benefit on metabolic control [37][38][39] (for reviews, see Davidson 11 and Kolb et al…”

Section: What Do the Guidelines Say On Smbg In Diabetes?mentioning

confidence: 99%

Self-Monitoring of Blood Glucose in Diabetes: From Evidence to Clinical Reality in Central and Eastern Europe—Recommendations from the International Central-Eastern European Expert Group

Czupryniak

Barkai

Bolgarska³

et al. 2014

Diabetes Technology & Therapeutics

View full text Add to dashboard Cite

Self-monitoring of blood glucose (SMBG) is universally considered to be an integral part of type 1 diabetes management and crucial for optimizing the safety and efficacy of complex insulin regimens. This extends to type 2 diabetes patients on intensive insulin therapy, and there is also a growing body of evidence suggesting that structured SMBG is beneficial for all type 2 diabetes patients, regardless of therapy. However, access to SMBG can be limited in many countries in Central and Eastern Europe. A consensus group of diabetes experts from 10 countries in this region (with overlapping historical, political, and social environments)-Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Serbia, Slovakia, Slovenia, and Ukraine-was formed to discuss the role of SMBG across the spectrum of patients with diabetes. The group considered SMBG to be an essential tool that should be accessible to all patients with diabetes, including those with non-insulin-treated type 2 diabetes. The current article summarizes the evidence put forward by the consensus group and provides their recommendations for the appropriate use of SMBG as part of individualized patient management. The ultimate goal of these evidence-based recommendations is to help patients and providers in Central and Eastern Europe to make optimal use of SMBG in order to maximize the efficacy and safety of glucose-lowering therapies, to prevent complications, and to empower the patient to play a more active role in the management of their diabetes.

show abstract

“…[5,8,9] However, some believe the utility of SMBG in non-insulin-treated T2DM remains controversial. [7,[10][11][12][13][14][15] Although many studies have reported negative findings regarding SMBG use in non-insulin-treated T2DM, they have simply shown that SMBG is valuable only when it is used effectively. Optimal SMBG use requires that both patients and health care professionals monitor, interpret, and respond appropriately to acute glucose excursions and patterns of glycemia identified through SMBG.…”

Section: Introductionmentioning

confidence: 99%

Self-monitoring of blood glucose among diabetic patients attending Al-Eskan Primary Health Care Center in Makkah Al-Mukarramah city

Mansouri¹,

Alawi²,

Barasyn³

et al. 2015

Int J Med Sci Public Health

View full text Add to dashboard Cite

Materials and Methods: A cross-sectional analytic study was conducted including a representative sample of diabetic Patients attending Al-Eskan Primary Health Care Center in Makkah Al-Mukarramah city. Every third patient who attended for follow-up in the center was recruited in the research until the target number was achieved. Two sets of questionnaires were developed in English language and validated in a Malaysian study, and consequently used in the present study. One set of questionnaire was for diabetic patients who performed self-monitoring consisted of five parts; personal data, information about the patient's diabetes and treatment, the patient's perception regarding diabetes and his health, the patient's belief and attitudes toward SMBG, and the patient's current SMBG practices. Another set of questionnaire was for those who did not perform self-monitoring. It was similar except in part 4 where different statements were used to assess the patient's perception and attitude toward SMBG. Results: The study included 120 patients with T2DM. The prevalence of SMBG among them was 70.8%. Among those who are practicing SMBG, 28.2% practiced it on daily basis whereas 10.6% practiced it more than once daily. Almost one third of them (35.3%) recorded their blood glucose monitoring results. Only 22.4% showed their results to their physicians and 25.9% adjusted their diabetes treatment based on blood glucose results. Sixty-nine respondents (57.5%) needed further help and information regarding diabetes with no significant association with SMBG practice. It was found that younger (≤50 years), male, married, and higher educated diabetic patients were more likely to practice SMBG, regardless of its frequency. All information related to diabetes (duration, therapy, complications, hospitalization, recent HbA1C, and attending educational sessions) was not significantly associated with SMBG practice. Conclusion: SMBG is widely used among patients with T2DM in Al-Eskan Primary Health Care Center in Makkah Al-Mukarramah city. However, its frequency and timing is suboptimal. As younger (≤50 years), male, married, and higher educated diabetic patients were more likely to practice SMBG.

show abstract

Randomized Studies are Needed to Assess the True Role of Self-Monitoring of Blood Glucose in Noninsulin-Treated Type 2 Diabetes

Cited by 7 publications

References 36 publications

A Pilot Study to Assess Clinical Utility and User Experience of Professional Continuous Glucose Monitoring Among People With Type 2 Diabetes

A Pilot Study to Assess Clinical Utility and User Experience of Professional Continuous Glucose Monitoring Among People With Type 2 Diabetes

Self-Monitoring of Blood Glucose in Diabetes: From Evidence to Clinical Reality in Central and Eastern Europe—Recommendations from the International Central-Eastern European Expert Group

Self-monitoring of blood glucose among diabetic patients attending Al-Eskan Primary Health Care Center in Makkah Al-Mukarramah city

Contact Info

Product

Resources

About